Research Unit, Oncology Division, Hospital Universitario Lucus Augusti (HULA), Servicio Galego de Saúde (SERGAS), Lugo, Spain.
Oncology Division, Hospital Universitario Lucus Augusti (HULA), Servicio Galego de Saúde (SERGAS), Lugo, Spain.
J Biol Inorg Chem. 2018 May;23(3):331-345. doi: 10.1007/s00775-018-1542-z. Epub 2018 Feb 16.
Nanoparticles are being actively developed for biomolecular profiling of cancer biomarkers, tumor imaging in vivo, and targeted drug delivery. These nanotechnology-based techniques can be applied widely in the management of different malignant diseases, such as breast cancer. Although the number of different types of nanoparticles is increasing rapidly, most can be classified into two major types: particles that contain organic molecules as a major building material (such as dendrimers, micelles, liposomes and carbon nanotubes, and other polymers); and those that use inorganic elements, usually metals, as a core. In particular, inorganic nanoparticles have received increased attention in the recent past as potential diagnostic and therapeutic systems in the field of oncology. This review primarily discusses progress in applications of inorganic nanoparticles for breast cancer imaging and treatment.
纳米粒子正被积极开发用于生物分子分析癌症生物标志物、体内肿瘤成像和靶向药物输送。这些基于纳米技术的技术可以广泛应用于不同恶性疾病的治疗,如乳腺癌。虽然不同类型的纳米粒子数量迅速增加,但大多数可以分为两类:一类是主要由有机分子作为主要建筑材料的粒子(如树枝状大分子、胶束、脂质体和碳纳米管等聚合物);另一类是使用无机元素,通常是金属作为核心的粒子。特别是,无机纳米粒子在最近的过去作为肿瘤学领域潜在的诊断和治疗系统引起了更多的关注。这篇综述主要讨论了无机纳米粒子在乳腺癌成像和治疗中的应用进展。